Zhongping Gu

676 total citations
25 papers, 541 citations indexed

About

Zhongping Gu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zhongping Gu has authored 25 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Zhongping Gu's work include Epigenetics and DNA Methylation (8 papers), Cancer-related gene regulation (7 papers) and Cancer-related Molecular Pathways (3 papers). Zhongping Gu is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer-related gene regulation (7 papers) and Cancer-related Molecular Pathways (3 papers). Zhongping Gu collaborates with scholars based in China and United States. Zhongping Gu's co-authors include Zhengxin Wang, Shen Gao, Wencai Ma, Fahao Zhang, Richard E. Davis, Zhiqiang Wang, Pengyu Jing, Zhipei Zhang, Peng Lee and Yirong Li and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhongping Gu

24 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongping Gu China 13 465 95 88 49 26 25 541
Shunsheng Zheng China 8 395 0.8× 93 1.0× 76 0.9× 33 0.7× 11 0.4× 8 454
Manuel Saiselet Belgium 10 302 0.6× 100 1.1× 213 2.4× 60 1.2× 11 0.4× 13 481
Wolong Zhou China 12 304 0.7× 96 1.0× 157 1.8× 79 1.6× 18 0.7× 21 427
Dimitris Karagiannis United States 8 376 0.8× 116 1.2× 116 1.3× 52 1.1× 8 0.3× 8 474
Janine M. Buonato United States 8 203 0.4× 141 1.5× 64 0.7× 56 1.1× 37 1.4× 10 322
Xingling Zheng China 9 322 0.7× 89 0.9× 95 1.1× 38 0.8× 28 1.1× 12 431
Jude Alsarraj United States 6 356 0.8× 141 1.5× 115 1.3× 41 0.8× 26 1.0× 6 469
Srilatha Nalluri United States 9 296 0.6× 61 0.6× 61 0.7× 31 0.6× 37 1.4× 9 369
Chang Hyeok An South Korea 10 252 0.5× 83 0.9× 107 1.2× 41 0.8× 16 0.6× 14 340
Chenyi Zhou China 11 196 0.4× 95 1.0× 71 0.8× 62 1.3× 12 0.5× 20 299

Countries citing papers authored by Zhongping Gu

Since Specialization
Citations

This map shows the geographic impact of Zhongping Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongping Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongping Gu more than expected).

Fields of papers citing papers by Zhongping Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongping Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongping Gu. The network helps show where Zhongping Gu may publish in the future.

Co-authorship network of co-authors of Zhongping Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongping Gu. A scholar is included among the top collaborators of Zhongping Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongping Gu. Zhongping Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, Hongjuan Lang, Yan Wang, et al.. (2025). Development and application of patient-reported experience measures for cancer patients: a scoping review. International Journal of Nursing Studies Advances. 8. 100327–100327.
2.
Liang, Ying, Pengyu Jing, Zhongping Gu, et al.. (2024). Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol. Trials. 25(1). 130–130. 2 indexed citations
3.
Li, Haichao, et al.. (2023). The PRMT5 inhibitor C9 mitigates hypoxia‐induced carboplatin resistance in lung cancer by inducing autophagy. Cell Biology International. 47(10). 1702–1715. 5 indexed citations
4.
Jing, Pengyu, et al.. (2023). Evaluation of an ex vivo fibrogenesis model using human lung slices prepared from small tissues. European journal of medical research. 28(1). 143–143. 6 indexed citations
5.
Sun, Ying, Yue Liu, Yu Wang, et al.. (2023). The human microbiome: A promising target for lung cancer treatment. Frontiers in Immunology. 14. 1091165–1091165. 12 indexed citations
6.
Jing, Pengyu, et al.. (2020). miR‐24‐3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT. Journal of Immunology Research. 2020(1). 4036047–4036047. 18 indexed citations
7.
Jing, Pengyu, et al.. (2018). The methylation induced by protein arginine methyltransferase 5 promotes tumorigenesis and progression of lung cancer. Journal of Thoracic Disease. 10(12). 7014–7019. 3 indexed citations
8.
Jing, Pengyu, Nan Zhao, Mingxiang Ye, et al.. (2018). Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling. Cancer Letters. 427. 38–48. 67 indexed citations
9.
Zhang, Xiang, Xiaofei Li, Zhongping Gu, et al.. (2018). A miR-124/ITGA3 axis contributes to colorectal cancer metastasis by regulating anoikis susceptibility. Biochemical and Biophysical Research Communications. 501(3). 758–764. 31 indexed citations
10.
Yu, Min, et al.. (2017). Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity. PLoS ONE. 12(8). e0181601–e0181601. 19 indexed citations
11.
Yi, Pengfei, Shen Gao, Zhongping Gu, Tao Huang, & Zhengxin Wang. (2014). P44/WDR77 restricts the sensitivity of proliferating cells to TGFβ signaling. Biochemical and Biophysical Research Communications. 450(1). 409–415. 11 indexed citations
12.
Zhou, Liran, et al.. (2013). cGMP-Dependent Protein Kinase Iβ Interacts with p44/WDR77 to Regulate Androgen Receptor-Driven Gene Expression. PLoS ONE. 8(6). e63119–e63119. 7 indexed citations
13.
Gu, Zhongping, Yirong Li, Peng Lee, et al.. (2012). Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells. PLoS ONE. 7(8). e44033–e44033. 71 indexed citations
14.
Gu, Zhongping, Liran Zhou, Shen Gao, & Zhengxin Wang. (2011). Nuclear Transport Signals Control Cellular Localization and Function of Androgen Receptor Cofactor p44/WDR77. PLoS ONE. 6(7). e22395–e22395. 19 indexed citations
15.
Zhou, Yongan, Tao Zhang, Jinbo Zhao, et al.. (2010). The Adenovirus-Mediated Transfer ofPTENInhibits the Growth of Esophageal Cancer Cellsin Vitroandin Vivo. Bioscience Biotechnology and Biochemistry. 74(4). 736–740. 12 indexed citations
16.
Zhao, Jinbo, Yongan Zhou, Zhipei Zhang, et al.. (2009). Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation. Cancer Letters. 290(2). 238–247. 37 indexed citations
17.
Zhang, Feng, Tao Zhang, Tao Jiang, et al.. (2009). Wortmannin potentiates roscovitine-induced growth inhibition in human solid tumor cells by repressing PI3K/Akt pathway. Cancer Letters. 286(2). 232–239. 19 indexed citations
18.
Zhang, Feng, Tao Zhang, Zhongping Gu, et al.. (2008). Enhancement of Radiosensitivity by Roscovitine Pretreatment in Human Non-small Cell Lung Cancer A549 Cells. Journal of Radiation Research. 49(5). 541–548. 26 indexed citations
19.
Gu, Zhongping. (2004). Synthesis of ribozyme against vascular endothelial growth factor165and its biological activityin vitro. World Journal of Gastroenterology. 10(10). 1495–1495. 3 indexed citations
20.
Gu, Zhongping. (2002). VEGF165antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma. World Journal of Gastroenterology. 8(1). 44–44. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunsheng Zheng Breakdown of academic impact, for papers by Manuel Saiselet Breakdown of academic impact, for papers by Wolong Zhou Breakdown of academic impact, for papers by Dimitris Karagiannis Breakdown of academic impact, for papers by Janine M. Buonato Breakdown of academic impact, for papers by Xingling Zheng Breakdown of academic impact, for papers by Jude Alsarraj Breakdown of academic impact, for papers by Srilatha Nalluri Breakdown of academic impact, for papers by Chang Hyeok An Breakdown of academic impact, for papers by Chenyi Zhou
Rankless by CCL
2026